IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

LUBRANO DI SCORPANIELLO, Ennio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.001
EU - Europa 9.209
AS - Asia 2.703
SA - Sud America 1.006
AF - Africa 464
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 25.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.814
RU - Federazione Russa 3.802
IE - Irlanda 1.958
SG - Singapore 1.196
BR - Brasile 822
CN - Cina 604
UA - Ucraina 544
IT - Italia 535
FI - Finlandia 457
AT - Austria 374
DE - Germania 373
CI - Costa d'Avorio 354
SE - Svezia 331
GB - Regno Unito 301
FR - Francia 283
VN - Vietnam 267
HK - Hong Kong 148
CA - Canada 111
IN - India 100
AR - Argentina 73
BD - Bangladesh 51
NL - Olanda 48
MX - Messico 46
JP - Giappone 43
ZA - Sudafrica 42
TR - Turchia 41
BE - Belgio 39
IQ - Iraq 36
ES - Italia 33
ID - Indonesia 31
CO - Colombia 30
PL - Polonia 28
EC - Ecuador 26
LT - Lituania 24
AU - Australia 20
IR - Iran 19
IL - Israele 16
KZ - Kazakistan 15
MA - Marocco 15
PK - Pakistan 15
SA - Arabia Saudita 15
CL - Cile 14
EU - Europa 14
KR - Corea 14
VE - Venezuela 13
EG - Egitto 12
JO - Giordania 12
AZ - Azerbaigian 11
RO - Romania 10
CZ - Repubblica Ceca 9
HR - Croazia 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
PE - Perù 8
TN - Tunisia 8
JM - Giamaica 7
PY - Paraguay 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
UZ - Uzbekistan 7
BO - Bolivia 6
CH - Svizzera 6
GR - Grecia 6
KE - Kenya 6
PA - Panama 6
PT - Portogallo 6
SN - Senegal 6
AL - Albania 5
BG - Bulgaria 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PH - Filippine 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
LK - Sri Lanka 4
TH - Thailandia 4
BY - Bielorussia 3
DK - Danimarca 3
GE - Georgia 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
CY - Cipro 2
GI - Gibilterra 2
KW - Kuwait 2
NG - Nigeria 2
NI - Nicaragua 2
TW - Taiwan 2
YT - Mayotte 2
BB - Barbados 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
Totale 25.407
Salva come PNG Salva come JPEG
Città #
Dallas 4.370
Dublin 1.958
Jacksonville 1.322
Moscow 1.221
Chandler 1.133
Singapore 597
Wilmington 409
Vienna 366
Abidjan 354
Helsinki 313
Ashburn 278
Rome 272
Houston 258
San Mateo 248
The Dalles 241
Beijing 205
Ann Arbor 185
Princeton 179
Los Angeles 156
Hong Kong 147
Boardman 146
Woodbridge 146
Columbus 106
Ho Chi Minh City 99
Dearborn 94
New York 94
São Paulo 79
Hanoi 46
Council Bluffs 45
Redwood City 41
Tokyo 39
Chicago 36
Mountain View 36
Brussels 35
London 35
Santa Clara 35
Brooklyn 34
Molise 34
Amsterdam 32
Toronto 32
Johannesburg 31
Rio de Janeiro 30
San Francisco 30
Montreal 29
Denver 27
Frankfurt am Main 27
Jinan 27
Atlanta 25
Warsaw 23
Manchester 22
Mexico City 20
Milan 20
Nuremberg 20
Seattle 20
Nanjing 19
Orem 18
Shenyang 18
Chennai 17
Falls Church 17
Guangzhou 17
Phoenix 17
Boston 16
Shanghai 16
Ottawa 15
Dhaka 14
Ningbo 14
Auburn Hills 13
Augusta 13
Leawood 13
Belo Horizonte 12
Haikou 12
Jakarta 12
Porto Alegre 12
Stockholm 12
Amman 11
Brasília 11
Falkenstein 11
Fortaleza 11
Ardabil 10
Assago 10
Baghdad 10
Baku 10
Bogotá 10
Dong Ket 10
Zhengzhou 10
Borås 9
Charlotte 9
Haiphong 9
Hải Dương 9
Istanbul 9
Ninh Bình 9
Norwalk 9
Paris 9
Rockville 9
St Louis 9
Taizhou 9
Campinas 8
Changsha 8
Curitiba 8
Esslingen am Neckar 8
Totale 16.349
Salva come PNG Salva come JPEG
Nome #
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action 2.682
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 218
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 180
An overview of low disease activity and remission in psoriatic arthritis. 179
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 176
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 176
An audit of anthropometric measurements by medical and physiotherapy staff in patients with ankylosing spondylitis 167
ANTHROPOMETRIC MEASUREMENTS AND DISABILITY IN A OPEN FOLLOW UP STUDY ON ANKYLOSING SPONDYLITIS WITH COMBINED MEDICAL AND REHABILITATIVE TREATMENT 160
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 159
Aortic involvement in ankylosing spondylitis 158
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 157
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 157
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 156
Antiphospholipid syndrome, activated protein C resistance and mutation C -> T 677 in the MTHFR gene with juvenile pulmonary embolism. A case report 155
A novel biological target for the treatment of psoriatic arthritis. 154
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 154
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 150
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 150
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 149
La spondilodiscite delle spondiloartriti sieronegative 144
Measuring psoriatic disease in clinical practice. An expert opinion position paper. 142
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 142
Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis 141
A rare enthesopathy in psoriatic oligoarthritis 141
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 139
Assessment of psoriatic nail disease activity by rheumatologists 138
A national survey on the management of psoriatic arthritis using the Delphi method 138
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients 133
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 133
Iperuricemia e rischio cardio-renale 133
Venous thrombophilia in a patient with protein S deficiency, factor V Leiden and homozygous MTHFR C -> T677 mutation 132
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 131
Pharmacoeconomic issues in psoriatic arthritis 129
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 129
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 129
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up 128
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 127
Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement 126
Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions 124
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 124
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? 123
Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis? 123
Simple clinical indicators for early psoriatic arthritis detection. 123
The arthritis of ulcerative colitis: clinical and genetic aspects 123
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies 123
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 122
The role of IL-17 in the treatment of psoriatic arthritis 122
Patient education in psoriatic arthritis: a cross sectional study on knowledge by a validated self-administered questionnaire 120
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 120
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 120
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 118
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 118
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 117
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: A systematic review. 115
The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire 115
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept 115
Venous thrombophilia with severe mesenteric involvement associated to homozygosity for factor V Leiden and heterozygosity for G20210A mutation of prothrombin 114
Secukinumab for ankylosing spondylitis and psoriatic arthritis 114
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 114
Trauma and seronegative spondylarthropathy 113
The performance of CASPAR criteria in early psoriatic arthritis - preliminary results from an Italian prospective multicentric study 113
Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey. 113
Unmet Needs in Axial Spondyloarthritis 113
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model 112
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. 112
Treatment options: NSAIDs and DMARDs 112
LA COMPLICANZA ARTICOLARE DELLA MALATTIA CELIACA. STUDIO SU 62 CASI: RISULTATI PRELIMINARI 112
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 112
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 111
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 111
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 111
Updated guidelines for the management of axial disease in psoriatic arthritis 111
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 111
Role of comorbidities in spondyloarthritis including psoriatic arthritis 111
Etanercept in psoriatic arthritis 111
Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis 110
Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation 110
Validity of the modified stoke ankylosing spondylitis spine score (M-SASSS) and of the bath ankylosing spondylitis radiology index (BASRI) for the radiological assessment of axial involvement in psoriatic arthritis. multicentre validation study. Part one. 110
Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? 110
Somatic perception in irritable bowel syndrome (IBS) patients with and without fibromyalgia (FMS). Does the severity of IBS influence the perception of somatic stimuli? 109
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 109
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology 109
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 109
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 109
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 109
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 108
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 108
Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis. 107
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. 107
Physical trauma triggers psoriasis in a patient with undifferentiated seronegative spondyloarthropathy 107
Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study 107
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 106
An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain 106
The effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria 106
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 105
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. 103
Current approach to the management of psoriatic arthritis according to a sample of Italian rheumatologists 103
Psoriatic disease: Clinical staging 102
An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 101
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 100
Totale 15.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021861 0 0 0 0 0 102 199 20 206 17 266 51
2021/2022968 51 252 16 31 55 28 29 106 141 154 43 62
2022/20234.662 535 121 102 392 245 377 16 220 2.328 146 82 98
2023/2024855 238 133 55 21 30 72 18 47 19 47 84 91
2024/20253.476 460 120 432 92 544 143 60 258 306 114 431 516
2025/202610.684 455 1.664 3.317 926 3.192 1.130 0 0 0 0 0 0
Totale 25.863